|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.45 CNY | -0.22% |
|
+2.16% | -49.92% |
| Oct. 25 | Changchun BCHT Biotechnology Co. Reports Earnings Results for the Nine Months Ended September 30, 2024 | CI |
| Aug. 16 | Changchun BCHT Biotechnology H1 Profit Up 24%, Operating Income Rises 11% | MT |
| Capitalization | 11.35B 1.56B 1.48B 1.37B 1.22B 2.21B 133B 2.42B 17.04B 6.29B 54.43B 5.87B 5.74B 236B | P/E ratio 2024 * |
16.4x | P/E ratio 2025 * | 14.3x |
|---|---|---|---|---|---|
| Enterprise value | 11.35B 1.56B 1.48B 1.37B 1.22B 2.21B 133B 2.42B 17.04B 6.29B 54.43B 5.87B 5.74B 236B | EV / Sales 2024 * |
5.76x | EV / Sales 2025 * | 4.49x |
| Free-Float |
-
| Yield 2024 * |
0.6% | Yield 2025 * | 0.97% |
More valuation ratios
* Estimated data
More news
| 1 day | -0.22% | ||
| 1 week | +2.16% | ||
| Current month | +4.10% | ||
| 1 month | -1.05% | ||
| 3 months | +21.68% | ||
| 6 months | -11.88% | ||
| Current year | -49.92% |
1 week
26.21
27.95
1 month
25.4230.33
Current year
21.1858.50
1 year
21.1859.50
3 years
21.1878.78
5 years
21.18135.88
10 years
21.18135.88
| Director | Title | Age | Since |
|---|---|---|---|
Wei Kong
CEO | Chief Executive Officer | 59 | 2003-12-31 |
Zhao Feng Meng
DFI | Director of Finance/CFO | 60 | 2019-01-31 |
Chang Lin Zhu
CTO | Chief Tech/Sci/R&D Officer | 56 | 2003-12-31 |
| Manager | Title | Age | Since |
|---|---|---|---|
Xiu Feng Li
BRD | Director/Board Member | 56 | 2004-02-29 |
Xing Gong Zhu
BRD | Director/Board Member | 58 | 2021-08-02 |
De Shen Zhang
BRD | Director/Board Member | 60 | 2019-02-20 |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| -0.22% | +2.16% | -52.42% | -64.82% | 1.57B | ||
| +1.40% | -0.11% | -0.21% | -36.88% | 64.21B | ||
| -1.65% | -1.24% | +0.55% | -23.04% | 8.34B | ||
| +1.36% | +0.97% | +22.80% | +54.18% | 6.16B | ||
| -4.87% | -7.14% | +74.41% | +98.01% | 6.05B | ||
| -4.81% | -5.65% | +7.43% | -4.53% | 5.61B | ||
| -3.01% | -2.04% | -3.33% | -32.29% | 3.31B | ||
| +0.33% | +1.23% | +22.59% | +28.87% | 2.27B | ||
| -1.32% | -1.69% | +36.31% | +22.92% | 2.05B | ||
| -1.59% | -2.74% | -32.36% | +30.05% | 2.05B | ||
| Average | -1.44% | -2.03% | +7.58% | +7.25% | 10.16B | |
| Weighted average by Cap. | +0.12% | -1.17% | +5.80% | -16.67% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 1.97B 271M 256M 238M 212M 383M 23.02B 420M 2.96B 1.09B 9.45B 1.02B 997M 40.98B | 2.53B 348M 329M 305M 272M 491M 29.52B 538M 3.79B 1.4B 12.11B 1.31B 1.28B 52.55B |
| Net income | 527M 72.55M 68.58M 63.62M 56.73M 102M 6.16B 112M 791M 292M 2.53B 272M 267M 10.96B | 791M 109M 103M 95.47M 85.14M 154M 9.24B 168M 1.19B 438M 3.79B 409M 400M 16.44B |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
1,241
Sector
Pharmaceuticals
Calendar
2025-03-12
- Q4 2024 Earnings Release (Projected)
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-12-09 | 27.45 ¥ | -0.22% | 3,146,191 |
| 24-12-06 | 27.51 ¥ | +2.57% | 4,451,427 |
| 24-12-05 | 26.82 ¥ | +1.75% | 2,723,713 |
| 24-12-04 | 26.36 ¥ | -1.09% | 2,216,831 |
| 24-12-03 | 26.65 ¥ | -0.82% | 2,508,616 |
End-of-day quote Shanghai S.E., December 08, 2024
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
27.45CNY
Average target price
31.98CNY
Spread / Average Target
+16.52%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 688276 Stock